07 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), and Janssen PMP, a division
Read More05 September 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), today announced that the
Read More18 August 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO; OTC: MGROF; FRA: 0C0) (“MustGrow”), an agricultural biotechnology company focused on providing science-based
Read More13 June 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce
Read More06 June 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce the signing
Read More24 May 2023, Canada: MustGrow Biologics Corp. (TSXV: MGRO) (OTC: MGROF) (FRA: 0C0) (the “Company“, “MustGrow“), and JANSSEN PMP, a division of Janssen Pharmaceutica NV,
Read More18 April 2023, Canada: MustGrow Biologics Corp., is pleased to report an additional area of sustainable agriculture opportunity that the Company
Read More09 March 2023, Canada: MustGrow Biologics Corp., is pleased to report on the growth of its intellectual property portfolio (the “IP Portfolio”)
Read More10 November 2022, Canada: MustGrow Biologics Corp. (CSE: MGRO; OTCQB: MGROF; FRA: 0C0) (the “Company” or “MustGrow”), is pleased to announce that the TSX
Read More11 October 2022, Canada: MustGrow Biologics Corp., is pleased to announce that it has received conditional approval to list its common
Read More
